Article
Cytochrome P450 in Pharmacogenetics: An Update.
Advances in pharmacology (San Diego, Calif.) - 1 Jan 2018
Tornio Aleksi, Backman Janne T
Abstract excerpt
Interindividual variability in drug disposition is a major cause of lack of efficacy and adverse effects of drug therapies. The majority of hepatically cleared drugs are metabolized by cytochrome P450 (CYP) enzymes, mainly in families CYP1, CYP2, and CYP3. Genes encoding these enzymes are highly variable with allele distribution showing considerable differences between populations. Genetic variability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
